SWEDEN - Can a blood test based on the ratio of plasma phosphorylated tau 217 (p-tau217) relative to non–p-tau217 (expressed as percentage of p-tau217) combined with the amyloid-β 42 and amyloid-β 40 plasma ratio (the amyloid probability score 2 [APS2]) accurately identify Alzheimer disease in primary care and secondary care when prospectively applying predefined biomarker
NEW YORK. - Our immune system is talented at telling the difference between the chemistry of our own body and that of an invading pathogen. When it malfunctions, our body can become host to an intense civil war. Scientists are keen to understand this in more detail, and a newly identified 'switch' that deactivates a
ANN ARBOR - LynxDx, an Ann Arbor diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to
DETROIT - The dream of eternal life is certainly as old as humanity. In fact, we have come a little closer to it over the years, as medical advances and improvements in circumstances have already significantly extended life expectancy. And now the next decisive step is to come. On the way to unlimited life expectancy Futurist and technology
GRAND RAPIDS—Priority Health, the Grand Rapids-based health insurer, announced a pilot of new incentives for providers who screen patients and submit information on Social Determinants of Health, making them the first insurer in the state to financially support this type of data tracking. According to the Centers for Disease Control and Prevention, SDoH are conditions
ANN ARBOR — Esperion Therapeutics Inc., the Ann Arbor-based pharmaceutical developer, announced positive results from the final Phase 3 test of its lead drug candidate, bempedoic acid. The company said a global, pivotal Phase 3 clinical study (Study 1002-047) showed that a dose of 180 milligrams per day of the drug showed additional lowering of
ANN ARBOR - Enzo Life Sciences has released its newest immunohistochemistry product, MULTIVIEW® PLUS (mouse-HRP/rabbit-AP) IHC Kit (Brown/Green). This non-biotin nanopolymer detection system contains reagents and materials that detect and localize antigens in formalin-fixed paraffin-embedded tissues. The new MULTIVIEW PLUS IHC kit optimizes your IHC process by including the entire workflow, from antigen retrieval to
